Hans G. Nilsson
Directeur/Membre du Conseil chez PharmNovo AB
Profil
Hans G.
Nilsson is currently the Director at PharmNovo AB since 2018.
Prior to this, he was the President at AstraZeneca R&D Boston, Inc.
Postes actifs de Hans G. Nilsson
| Sociétés | Poste | Début |
|---|---|---|
PharmNovo AB
 PharmNovo AB Miscellaneous Commercial ServicesCommercial Services PharmNovo AB operates as an biotechnology company. It cures diseases related to pain management such as anxiety, depression, chronic pain, neuroprotection, and osteoarthritis. The company was founded by Bengt von Mentzer in 2008 and is headquartered in Lund, Sweden. | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de Hans G. Nilsson
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca R&D Boston, Inc.
 AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca R&D Boston, Inc. develops, manufactures and markets prescription pharmaceutical drugs. The company is headquartered in Cambridge, MA. | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca R&D Boston, Inc. develops, manufactures and markets prescription pharmaceutical drugs. The company is headquartered in Cambridge, MA. | Health Technology |
PharmNovo AB
PharmNovo AB Miscellaneous Commercial ServicesCommercial Services PharmNovo AB operates as an biotechnology company. It cures diseases related to pain management such as anxiety, depression, chronic pain, neuroprotection, and osteoarthritis. The company was founded by Bengt von Mentzer in 2008 and is headquartered in Lund, Sweden. | Commercial Services |
